XML 22 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating activities:    
Net income (loss) $ 101 $ (78)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Amortization of deferred financing costs and debt discount 15 15
Impairment expense 0 129
Depreciation and amortization 536 490
Inventory market valuation adjustment 0 15
Pension and other postretirement benefits, net 27 30
Deferred income taxes (5) (2)
Net gain on disposal of assets (5) (25)
Income from equity method investments (57) (22)
Distributions from equity method investments 61 50
Changes in the fair value of derivative instruments 28 (18)
Changes in:    
Current receivables 333 325
Inventories 264 226
Current accounts payable and accrued liabilities (215) (810)
All other, net 30 5
Net cash provided by operating activities 1,113 330
Investing activities:    
Additions to property, plant and equipment (610) (745)
Acquisitions (220) 0
Disposal of assets 2 77
Investments – acquisitions, loans and contributions (566) (66)
Investments - redemptions, repayments and return of capital 15 0
All other, net 23 7
Net cash used in investing activities (1,356) (727)
Financing activities:    
Commercial paper – issued 300 264
Commercial paper - repayments (300) (76)
Long-term debt – borrowings 2,241 586
Long-term debt – repayments (207) (1,145)
Debt issuance costs (21) (1)
Issuance of common stock 10 1
Common stock repurchased (420) (75)
Dividends paid (190) (169)
Issuance of MPLX LP common units 148 315
Distributions to noncontrolling interests (158) (121)
Contributions from noncontrolling interests 126 2
All other, net (6) (3)
Net cash provided by (used in) financing activities 1,523 (422)
Net increase (decrease) in cash and cash equivalents 1,280 (819)
Cash and cash equivalents at beginning of period 887 1,127
Cash and cash equivalents at end of period $ 2,167 $ 308